{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:50:40Z","timestamp":1792590640946,"version":"4.5.0"},"reference-count":23,"publisher":"MyJove Corporation","issue":"232","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/71268","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:00:44Z","timestamp":1781046044000},"source":"Crossref","is-referenced-by-count":0,"title":["<em>In Vitro<\/em> Functional Analysis of Regulatory T cells: Focus On Proliferation And Differentiation"],"prefix":"10.3791","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlai","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","type":"journal-article","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7):490-500.","journal-title":"Nat Rev Immunol"},{"issue":"8066","key":"ref2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41586-025-08795-5","type":"journal-article","article-title":"Genome-wide CRISPR screen in human T cells reveals regulators of FOXP3","volume":"642","author":"Chen","year":"2025","unstructured":"Chen KY, et al. Genome-wide CRISPR screen in human T cells reveals regulators of FOXP3. Nature. 2025;642(8066):191-200.","journal-title":"Nature"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","type":"journal-article","article-title":"Treg cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","unstructured":"Raffin C, Vo LT, Bluestone JA. Treg cell-based therapies: challenges and perspectives. Nat Rev Immunol. 2020;20(3):158-72.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2217\/imt.15.79","type":"journal-article","article-title":"Manipulating regulatory T cells: a promising strategy to treat autoimmunity","volume":"7","author":"Zhang","year":"2015","unstructured":"Zhang D, et al. Manipulating regulatory T cells: a promising strategy to treat autoimmunity. Immunotherapy. 2015;7(11):1201-11.","journal-title":"Immunotherapy"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-024-01089-x","type":"journal-article","article-title":"Harnessing the biology of regulatory T cells to treat disease","volume":"24","author":"Wardell","year":"2025","unstructured":"Wardell CM, Boardman DA, Levings MK. Harnessing the biology of regulatory T cells to treat disease. Nat Rev Drug Discov. 2025;24(2):93-111.","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41568-025-00832-9","type":"journal-article","article-title":"Regulatory T cells in the tumour microenvironment","volume":"25","author":"Imianowski","year":"2025","unstructured":"Imianowski CJ, Chen Q, Workman CJ, Vignali DAA. Regulatory T cells in the tumour microenvironment. Nat Rev Cancer. 2025;25(9):703-22.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","type":"journal-article","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","unstructured":"Tay C, Tanaka A, Sakaguchi S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell. 2023;41(3):450-65.","journal-title":"Cancer Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1081644","DOI":"10.3389\/fcell.2022.1081644","type":"journal-article","article-title":"Clinical adoptive regulatory T cell therapy: state of the art, challenges, and prospective","volume":"10","author":"Amini","year":"2022","unstructured":"Amini L, et al. Clinical adoptive regulatory T cell therapy: state of the art, challenges, and prospective. Front Cell Dev Biol. 2022;10:1081644.","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/ard-2022-222501","type":"journal-article","article-title":"Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial","volume":"81","author":"Humrich","year":"2022","unstructured":"Humrich JY, et al. Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial. Ann Rheum Dis. 2022;81(12):1685-94.","journal-title":"Ann Rheum Dis"},{"issue":"315","key":"ref10","doi-asserted-by":"crossref","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","type":"journal-article","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","unstructured":"Bluestone JA, et al. Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci Transl Med. 2015;7(315):315ra189.","journal-title":"Sci Transl Med"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.it.2023.04.005","type":"journal-article","article-title":"Engineered Treg cells as putative therapeutics against inflammatory diseases and beyond","volume":"44","author":"Bittner","year":"2023","unstructured":"Bittner S, Hehlgans T, Feuerer M. Engineered Treg cells as putative therapeutics against inflammatory diseases and beyond. Trends Immunol. 2023;44(6):468-83.","journal-title":"Trends Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"102986","DOI":"10.1016\/j.jaut.2022.102986","type":"journal-article","article-title":"Engineered Treg cells: the heir to the throne of immunotherapy","volume":"144","author":"Stucchi","year":"2024","unstructured":"Stucchi A, Maspes F, Montee-Rodrigues E, Fousteri G. Engineered Treg cells: the heir to the throne of immunotherapy. J Autoimmun. 2024;144:102986.","journal-title":"J Autoimmun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-61737-979-6_2","type":"journal-article","article-title":"In vitro Treg suppression assays","volume":"707","author":"Collison","year":"2011","unstructured":"Collison LW, Vignali DA. In vitro Treg suppression assays. Methods Mol Biol. 2011;707:21-37.","journal-title":"Methods Mol Biol"},{"issue":"193","key":"ref14","first-page":"e64918","type":"journal-article","article-title":"Simultaneous assessment of kinship, division number, and phenotype via flow cytometry for hematopoietic stem and progenitor cells","author":"Donada","year":"2023","unstructured":"Donada A, et al. Simultaneous assessment of kinship, division number, and phenotype via flow cytometry for hematopoietic stem and progenitor cells. J Vis Exp. 2023;(193):e64918.","journal-title":"J Vis Exp"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.immuni.2017.03.015","type":"journal-article","article-title":"Transforming growth factor-beta signaling in regulatory T cells controls T helper-17 cells and tissue-specific immune responses","volume":"46","author":"Konkel","year":"2017","unstructured":"Konkel JE, et al. Transforming growth factor-beta signaling in regulatory T cells controls T helper-17 cells and tissue-specific immune responses. Immunity. 2017;46(4):660-74.","journal-title":"Immunity"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1038\/s41467-025-62628-7","type":"journal-article","article-title":"Regulatory T cell therapy promotes TGF-beta and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2","volume":"16","author":"Cheng","year":"2025","unstructured":"Cheng H, et al. Regulatory T cell therapy promotes TGF-beta and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2. Nat Commun. 2025;16(1):7644.","journal-title":"Nat Commun"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","type":"journal-article","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","unstructured":"Joller N, et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity. 2014;40(4):569-81.","journal-title":"Immunity"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/CBI20100528","type":"journal-article","article-title":"The suppressive effect of CD25+Treg cells on Th1 differentiation requires cell-cell contact partially via TGF-beta production","volume":"35","author":"Shen","year":"2011","unstructured":"Shen E, Zhao K, Wu C, Yang B. The suppressive effect of CD25+Treg cells on Th1 differentiation requires cell-cell contact partially via TGF-beta production. Cell Biol Int. 2011;35(7):705-12.","journal-title":"Cell Biol Int"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10620-010-1286-2","type":"journal-article","article-title":"CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model","volume":"56","author":"Ogino","year":"2011","unstructured":"Ogino H, et al. CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model. Dig Dis Sci. 2011;56(2):376-86.","journal-title":"Dig Dis Sci"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.4049\/jimmunol.181.12.8209","type":"journal-article","article-title":"Cutting edge: antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease","volume":"181","author":"Huter","year":"2008","unstructured":"Huter EN, et al. Cutting edge: antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease. J Immunol. 2008;181(12):8209-13.","journal-title":"J Immunol"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-020-0435-8","type":"journal-article","article-title":"Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development","volume":"52","author":"Hwang","year":"2020","unstructured":"Hwang JR, Byeon Y, Kim D, Park SG. Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development. Exp Mol Med. 2020;52(5):750-61.","journal-title":"Exp Mol Med"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2018.03.025","type":"journal-article","article-title":"T cell receptor-regulated TGF-beta type I receptor expression determines T cell quiescence and activation","volume":"48","author":"Tu","year":"2018","unstructured":"Tu E, et al. T cell receptor-regulated TGF-beta type I receptor expression determines T cell quiescence and activation. Immunity. 2018;48(4):745-59.e6.","journal-title":"Immunity"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/nm.4375","type":"journal-article","article-title":"D-mannose induces regulatory T cells and suppresses immunopathology","volume":"23","author":"Zhang","year":"2017","unstructured":"Zhang D, et al. D-mannose induces regulatory T cells and suppresses immunopathology. Nat Med. 2017;23(9):1036-45.","journal-title":"Nat Med"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/71268\/in-vitro-functional-analysis-regulatory-t-cells-focus-on","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:33:49Z","timestamp":1792589629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/71268\/in-vitro-functional-analysis-regulatory-t-cells-focus-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":23,"journal-issue":{"issue":"232","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/71268","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]}}}